1. Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection. (6th July 2020) Authors: Bontempi, I; Leal, K; Prochetto, E; Díaz, G; Cabrera, G; Bortolotti, A; Morbidoni, H R; Borsuk, S; Dellagostin, O; Marcipar, I Journal: Clinical and experimental immunology Issue: Volume 201:Number 3(2020) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗